These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 39126705)

  • 1. Rescue of Scn5a mis-splicing does not improve the structural and functional heart defects of a DM1 heart mouse model.
    Nitschke L; Hu RC; Miller AN; Cooper TA
    Hum Mol Genet; 2024 Oct; 33(20):1789-1799. PubMed ID: 39126705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.
    Freyermuth F; Rau F; Kokunai Y; Linke T; Sellier C; Nakamori M; Kino Y; Arandel L; Jollet A; Thibault C; Philipps M; Vicaire S; Jost B; Udd B; Day JW; Duboc D; Wahbi K; Matsumura T; Fujimura H; Mochizuki H; Deryckere F; Kimura T; Nukina N; Ishiura S; Lacroix V; Campan-Fournier A; Navratil V; Chautard E; Auboeuf D; Horie M; Imoto K; Lee KY; Swanson MS; de Munain AL; Inada S; Itoh H; Nakazawa K; Ashihara T; Wang E; Zimmer T; Furling D; Takahashi MP; Charlet-Berguerand N
    Nat Commun; 2016 Apr; 7():11067. PubMed ID: 27063795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR -Mediated Expression of the Fetal Scn5a Isoform in Adult Mice Causes Conduction Defects and Arrhythmias.
    Pang PD; Alsina KM; Cao S; Koushik AB; Wehrens XHT; Cooper TA
    J Am Heart Assoc; 2018 Oct; 7(19):e010393. PubMed ID: 30371314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
    Suenaga K; Lee KY; Nakamori M; Tatsumi Y; Takahashi MP; Fujimura H; Jinnai K; Yoshikawa H; Du H; Ares M; Swanson MS; Kimura T
    PLoS One; 2012; 7(3):e33218. PubMed ID: 22427994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Evaluation of Chimeric LNA/2'-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy.
    Christou M; Wengel J; Sokratous K; Kyriacou K; Nikolaou G; Phylactou LA; Mastroyiannopoulos NP
    Nucleic Acid Ther; 2020 Apr; 30(2):80-93. PubMed ID: 31873063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded CCUG repeat RNA expression in Drosophila heart and muscle trigger Myotonic Dystrophy type 1-like phenotypes and activate autophagocytosis genes.
    Cerro-Herreros E; Chakraborty M; Pérez-Alonso M; Artero R; Llamusí B
    Sci Rep; 2017 Jun; 7(1):2843. PubMed ID: 28588248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible cardiac disease features in an inducible CUG repeat RNA-expressing mouse model of myotonic dystrophy.
    Rao AN; Campbell HM; Guan X; Word TA; Wehrens XH; Xia Z; Cooper TA
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33497365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
    Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
    J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic ventricular fibrillation and the V1764fsX1786 frameshift mutation of the SCN5A gene in a myotonic dystrophy type 1 patient.
    Shimoyama T; Hayashi H; Suzuki F; Nishiyama Y; Miyamoto Y; Aiba T; Shimizu W; Kimura K
    J Clin Neurosci; 2020 Apr; 74():242-244. PubMed ID: 32063450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy.
    Wang PY; Lin YM; Wang LH; Kuo TY; Cheng SJ; Wang GS
    Hum Mol Genet; 2017 Jun; 26(12):2247-2257. PubMed ID: 28369378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial effects of ion channel mis-splicing as a cause of myopathy in myotonic dystrophy.
    Nitschke L; Cooper TA
    J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 38165037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.
    Yadava RS; Yu Q; Mandal M; Rigo F; Bennett CF; Mahadevan MS
    Hum Mol Genet; 2020 Jun; 29(9):1440-1453. PubMed ID: 32242217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a
    Chakraborty M; Sellier C; Ney M; Pascal V; Charlet-Berguerand N; Artero R; Llamusi B
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29592894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A flow cytometry-based screen identifies MBNL1 modulators that rescue splicing defects in myotonic dystrophy type I.
    Zhang F; Bodycombe NE; Haskell KM; Sun YL; Wang ET; Morris CA; Jones LH; Wood LD; Pletcher MT
    Hum Mol Genet; 2017 Aug; 26(16):3056-3068. PubMed ID: 28535287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis].
    Furling D
    Rinsho Shinkeigaku; 2012; 52(11):1018-22. PubMed ID: 23196502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.